nodes	percent_of_prediction	percent_of_DWPC	metapath
Posaconazole—ABCB1—esophageal cancer	0.7	1	CbGaD
Posaconazole—Ketoconazole—CYP26A1—esophageal cancer	0.00576	0.503	CrCbGaD
Posaconazole—Ketoconazole—CYP1B1—esophageal cancer	0.00174	0.152	CrCbGaD
Posaconazole—Ketoconazole—CYP2A6—esophageal cancer	0.00134	0.117	CrCbGaD
Posaconazole—Ketoconazole—CYP19A1—esophageal cancer	0.00128	0.111	CrCbGaD
Posaconazole—Itraconazole—ABCB1—esophageal cancer	0.000833	0.0728	CrCbGaD
Posaconazole—ABCB1—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.000643	0.0633	CbGpPWpGaD
Posaconazole—Ketoconazole—ABCB1—esophageal cancer	0.000499	0.0436	CrCbGaD
Posaconazole—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000413	0.00148	CcSEcCtD
Posaconazole—Muscular weakness—Capecitabine—esophageal cancer	0.000413	0.00148	CcSEcCtD
Posaconazole—Eye disorder—Cisplatin—esophageal cancer	0.00041	0.00147	CcSEcCtD
Posaconazole—Tinnitus—Cisplatin—esophageal cancer	0.000409	0.00147	CcSEcCtD
Posaconazole—Lymphadenopathy—Methotrexate—esophageal cancer	0.000408	0.00147	CcSEcCtD
Posaconazole—Cardiac disorder—Cisplatin—esophageal cancer	0.000407	0.00146	CcSEcCtD
Posaconazole—Flushing—Cisplatin—esophageal cancer	0.000407	0.00146	CcSEcCtD
Posaconazole—Abdominal distension—Capecitabine—esophageal cancer	0.000407	0.00146	CcSEcCtD
Posaconazole—Dysphagia—Capecitabine—esophageal cancer	0.000404	0.00145	CcSEcCtD
Posaconazole—Thrombophlebitis—Methotrexate—esophageal cancer	0.000402	0.00145	CcSEcCtD
Posaconazole—Immune system disorder—Cisplatin—esophageal cancer	0.000397	0.00143	CcSEcCtD
Posaconazole—CYP3A4—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.000396	0.039	CbGpPWpGaD
Posaconazole—Mediastinal disorder—Cisplatin—esophageal cancer	0.000396	0.00142	CcSEcCtD
Posaconazole—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.000395	0.0388	CbGpPWpGaD
Posaconazole—Sweating increased—Capecitabine—esophageal cancer	0.000394	0.00142	CcSEcCtD
Posaconazole—Arrhythmia—Cisplatin—esophageal cancer	0.000392	0.00141	CcSEcCtD
Posaconazole—Alopecia—Cisplatin—esophageal cancer	0.000388	0.00139	CcSEcCtD
Posaconazole—Hepatic failure—Methotrexate—esophageal cancer	0.000388	0.00139	CcSEcCtD
Posaconazole—Pancytopenia—Capecitabine—esophageal cancer	0.000384	0.00138	CcSEcCtD
Posaconazole—Erythema—Cisplatin—esophageal cancer	0.000382	0.00137	CcSEcCtD
Posaconazole—Malnutrition—Cisplatin—esophageal cancer	0.000382	0.00137	CcSEcCtD
Posaconazole—Dysuria—Capecitabine—esophageal cancer	0.000378	0.00136	CcSEcCtD
Posaconazole—Neutropenia—Capecitabine—esophageal cancer	0.000378	0.00136	CcSEcCtD
Posaconazole—Renal failure acute—Methotrexate—esophageal cancer	0.000377	0.00136	CcSEcCtD
Posaconazole—Flatulence—Cisplatin—esophageal cancer	0.000377	0.00135	CcSEcCtD
Posaconazole—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000376	0.00135	CcSEcCtD
Posaconazole—Weight increased—Capecitabine—esophageal cancer	0.000368	0.00132	CcSEcCtD
Posaconazole—Muscle spasms—Cisplatin—esophageal cancer	0.000367	0.00132	CcSEcCtD
Posaconazole—Weight decreased—Capecitabine—esophageal cancer	0.000366	0.00131	CcSEcCtD
Posaconazole—Hyperglycaemia—Capecitabine—esophageal cancer	0.000365	0.00131	CcSEcCtD
Posaconazole—Pneumonia—Capecitabine—esophageal cancer	0.000363	0.0013	CcSEcCtD
Posaconazole—Infestation NOS—Capecitabine—esophageal cancer	0.000361	0.0013	CcSEcCtD
Posaconazole—Infestation—Capecitabine—esophageal cancer	0.000361	0.0013	CcSEcCtD
Posaconazole—Vision blurred—Cisplatin—esophageal cancer	0.00036	0.00129	CcSEcCtD
Posaconazole—Tremor—Cisplatin—esophageal cancer	0.000358	0.00129	CcSEcCtD
Posaconazole—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000357	0.00128	CcSEcCtD
Posaconazole—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000355	0.00128	CcSEcCtD
Posaconazole—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000355	0.00128	CcSEcCtD
Posaconazole—Ill-defined disorder—Cisplatin—esophageal cancer	0.000355	0.00127	CcSEcCtD
Posaconazole—Renal failure—Capecitabine—esophageal cancer	0.000354	0.00127	CcSEcCtD
Posaconazole—Myocardial infarction—Capecitabine—esophageal cancer	0.000353	0.00127	CcSEcCtD
Posaconazole—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000353	0.00127	CcSEcCtD
Posaconazole—Anaemia—Cisplatin—esophageal cancer	0.000353	0.00127	CcSEcCtD
Posaconazole—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.000352	0.0346	CbGpPWpGaD
Posaconazole—Stomatitis—Capecitabine—esophageal cancer	0.000351	0.00126	CcSEcCtD
Posaconazole—Jaundice—Capecitabine—esophageal cancer	0.000351	0.00126	CcSEcCtD
Posaconazole—Urinary tract infection—Capecitabine—esophageal cancer	0.00035	0.00126	CcSEcCtD
Posaconazole—Conjunctivitis—Capecitabine—esophageal cancer	0.00035	0.00126	CcSEcCtD
Posaconazole—Malaise—Cisplatin—esophageal cancer	0.000345	0.00124	CcSEcCtD
Posaconazole—Haematuria—Capecitabine—esophageal cancer	0.000344	0.00124	CcSEcCtD
Posaconazole—Leukopenia—Cisplatin—esophageal cancer	0.000342	0.00123	CcSEcCtD
Posaconazole—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000341	0.00123	CcSEcCtD
Posaconazole—Epistaxis—Capecitabine—esophageal cancer	0.00034	0.00122	CcSEcCtD
Posaconazole—Agranulocytosis—Capecitabine—esophageal cancer	0.000336	0.00121	CcSEcCtD
Posaconazole—Convulsion—Cisplatin—esophageal cancer	0.000331	0.00119	CcSEcCtD
Posaconazole—Mood swings—Methotrexate—esophageal cancer	0.00033	0.00119	CcSEcCtD
Posaconazole—Bradycardia—Capecitabine—esophageal cancer	0.000329	0.00118	CcSEcCtD
Posaconazole—Ataxia—Methotrexate—esophageal cancer	0.000327	0.00118	CcSEcCtD
Posaconazole—Myalgia—Cisplatin—esophageal cancer	0.000325	0.00117	CcSEcCtD
Posaconazole—Haemoglobin—Capecitabine—esophageal cancer	0.000325	0.00117	CcSEcCtD
Posaconazole—Rhinitis—Capecitabine—esophageal cancer	0.000324	0.00117	CcSEcCtD
Posaconazole—Anxiety—Cisplatin—esophageal cancer	0.000324	0.00117	CcSEcCtD
Posaconazole—Haemorrhage—Capecitabine—esophageal cancer	0.000324	0.00116	CcSEcCtD
Posaconazole—Hepatitis—Capecitabine—esophageal cancer	0.000324	0.00116	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000323	0.00116	CcSEcCtD
Posaconazole—Hypoaesthesia—Capecitabine—esophageal cancer	0.000322	0.00116	CcSEcCtD
Posaconazole—Liver function test abnormal—Methotrexate—esophageal cancer	0.000322	0.00116	CcSEcCtD
Posaconazole—Discomfort—Cisplatin—esophageal cancer	0.000321	0.00116	CcSEcCtD
Posaconazole—Pharyngitis—Capecitabine—esophageal cancer	0.000321	0.00115	CcSEcCtD
Posaconazole—Urinary tract disorder—Capecitabine—esophageal cancer	0.00032	0.00115	CcSEcCtD
Posaconazole—Oedema peripheral—Capecitabine—esophageal cancer	0.000319	0.00115	CcSEcCtD
Posaconazole—Connective tissue disorder—Capecitabine—esophageal cancer	0.000318	0.00114	CcSEcCtD
Posaconazole—Urethral disorder—Capecitabine—esophageal cancer	0.000317	0.00114	CcSEcCtD
Posaconazole—Breast disorder—Methotrexate—esophageal cancer	0.000315	0.00113	CcSEcCtD
Posaconazole—CYP3A4—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.000313	0.0308	CbGpPWpGaD
Posaconazole—Oedema—Cisplatin—esophageal cancer	0.000312	0.00112	CcSEcCtD
Posaconazole—Infection—Cisplatin—esophageal cancer	0.00031	0.00111	CcSEcCtD
Posaconazole—Erythema multiforme—Capecitabine—esophageal cancer	0.000306	0.0011	CcSEcCtD
Posaconazole—Nervous system disorder—Cisplatin—esophageal cancer	0.000306	0.0011	CcSEcCtD
Posaconazole—Thrombocytopenia—Cisplatin—esophageal cancer	0.000305	0.0011	CcSEcCtD
Posaconazole—Tachycardia—Cisplatin—esophageal cancer	0.000304	0.00109	CcSEcCtD
Posaconazole—Skin disorder—Cisplatin—esophageal cancer	0.000303	0.00109	CcSEcCtD
Posaconazole—Eye disorder—Capecitabine—esophageal cancer	0.000302	0.00109	CcSEcCtD
Posaconazole—Tinnitus—Capecitabine—esophageal cancer	0.000302	0.00108	CcSEcCtD
Posaconazole—Hyperhidrosis—Cisplatin—esophageal cancer	0.000302	0.00108	CcSEcCtD
Posaconazole—Cardiac disorder—Capecitabine—esophageal cancer	0.0003	0.00108	CcSEcCtD
Posaconazole—Flushing—Capecitabine—esophageal cancer	0.0003	0.00108	CcSEcCtD
Posaconazole—Eosinophilia—Methotrexate—esophageal cancer	0.000298	0.00107	CcSEcCtD
Posaconazole—Anorexia—Cisplatin—esophageal cancer	0.000297	0.00107	CcSEcCtD
Posaconazole—Pancreatitis—Methotrexate—esophageal cancer	0.000295	0.00106	CcSEcCtD
Posaconazole—Angiopathy—Capecitabine—esophageal cancer	0.000294	0.00106	CcSEcCtD
Posaconazole—Immune system disorder—Capecitabine—esophageal cancer	0.000292	0.00105	CcSEcCtD
Posaconazole—Mediastinal disorder—Capecitabine—esophageal cancer	0.000292	0.00105	CcSEcCtD
Posaconazole—Hypotension—Cisplatin—esophageal cancer	0.000291	0.00105	CcSEcCtD
Posaconazole—Chills—Capecitabine—esophageal cancer	0.00029	0.00104	CcSEcCtD
Posaconazole—Arrhythmia—Capecitabine—esophageal cancer	0.000289	0.00104	CcSEcCtD
Posaconazole—Alopecia—Capecitabine—esophageal cancer	0.000286	0.00103	CcSEcCtD
Posaconazole—Pancytopenia—Methotrexate—esophageal cancer	0.000286	0.00103	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000284	0.00102	CcSEcCtD
Posaconazole—Mental disorder—Capecitabine—esophageal cancer	0.000284	0.00102	CcSEcCtD
Posaconazole—Malnutrition—Capecitabine—esophageal cancer	0.000282	0.00101	CcSEcCtD
Posaconazole—Erythema—Capecitabine—esophageal cancer	0.000282	0.00101	CcSEcCtD
Posaconazole—Dysuria—Methotrexate—esophageal cancer	0.000281	0.00101	CcSEcCtD
Posaconazole—Neutropenia—Methotrexate—esophageal cancer	0.000281	0.00101	CcSEcCtD
Posaconazole—Paraesthesia—Cisplatin—esophageal cancer	0.00028	0.00101	CcSEcCtD
Posaconazole—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00028	0.00101	CcSEcCtD
Posaconazole—Dyspnoea—Cisplatin—esophageal cancer	0.000278	0.000999	CcSEcCtD
Posaconazole—Flatulence—Capecitabine—esophageal cancer	0.000278	0.000998	CcSEcCtD
Posaconazole—Dysgeusia—Capecitabine—esophageal cancer	0.000276	0.000991	CcSEcCtD
Posaconazole—CYP3A4—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.000275	0.0271	CbGpPWpGaD
Posaconazole—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.000275	0.027	CbGpPWpGaD
Posaconazole—Back pain—Capecitabine—esophageal cancer	0.000273	0.000979	CcSEcCtD
Posaconazole—Decreased appetite—Cisplatin—esophageal cancer	0.000271	0.000974	CcSEcCtD
Posaconazole—Muscle spasms—Capecitabine—esophageal cancer	0.000271	0.000973	CcSEcCtD
Posaconazole—Pneumonia—Methotrexate—esophageal cancer	0.00027	0.00097	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000269	0.000968	CcSEcCtD
Posaconazole—Infestation NOS—Methotrexate—esophageal cancer	0.000268	0.000964	CcSEcCtD
Posaconazole—Infestation—Methotrexate—esophageal cancer	0.000268	0.000964	CcSEcCtD
Posaconazole—Pain—Cisplatin—esophageal cancer	0.000267	0.000959	CcSEcCtD
Posaconazole—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000266	0.000956	CcSEcCtD
Posaconazole—Vision blurred—Capecitabine—esophageal cancer	0.000266	0.000954	CcSEcCtD
Posaconazole—Tremor—Capecitabine—esophageal cancer	0.000264	0.000949	CcSEcCtD
Posaconazole—Renal failure—Methotrexate—esophageal cancer	0.000264	0.000948	CcSEcCtD
Posaconazole—Stomatitis—Methotrexate—esophageal cancer	0.000262	0.00094	CcSEcCtD
Posaconazole—Ill-defined disorder—Capecitabine—esophageal cancer	0.000261	0.000939	CcSEcCtD
Posaconazole—Conjunctivitis—Methotrexate—esophageal cancer	0.000261	0.000938	CcSEcCtD
Posaconazole—Anaemia—Capecitabine—esophageal cancer	0.00026	0.000936	CcSEcCtD
Posaconazole—Feeling abnormal—Cisplatin—esophageal cancer	0.000257	0.000924	CcSEcCtD
Posaconazole—Haematuria—Methotrexate—esophageal cancer	0.000256	0.00092	CcSEcCtD
Posaconazole—Malaise—Capecitabine—esophageal cancer	0.000254	0.000913	CcSEcCtD
Posaconazole—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000254	0.000912	CcSEcCtD
Posaconazole—CYP3A4—Irinotecan Pathway—ABCC2—esophageal cancer	0.000253	0.0249	CbGpPWpGaD
Posaconazole—Epistaxis—Methotrexate—esophageal cancer	0.000253	0.00091	CcSEcCtD
Posaconazole—Vertigo—Capecitabine—esophageal cancer	0.000253	0.00091	CcSEcCtD
Posaconazole—Syncope—Capecitabine—esophageal cancer	0.000253	0.000908	CcSEcCtD
Posaconazole—Leukopenia—Capecitabine—esophageal cancer	0.000252	0.000906	CcSEcCtD
Posaconazole—Agranulocytosis—Methotrexate—esophageal cancer	0.00025	0.0009	CcSEcCtD
Posaconazole—Loss of consciousness—Capecitabine—esophageal cancer	0.000248	0.00089	CcSEcCtD
Posaconazole—Body temperature increased—Cisplatin—esophageal cancer	0.000247	0.000886	CcSEcCtD
Posaconazole—Cough—Capecitabine—esophageal cancer	0.000246	0.000884	CcSEcCtD
Posaconazole—Hypertension—Capecitabine—esophageal cancer	0.000243	0.000874	CcSEcCtD
Posaconazole—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.000243	0.0239	CbGpPWpGaD
Posaconazole—Haemoglobin—Methotrexate—esophageal cancer	0.000242	0.00087	CcSEcCtD
Posaconazole—Hepatitis—Methotrexate—esophageal cancer	0.000241	0.000866	CcSEcCtD
Posaconazole—Haemorrhage—Methotrexate—esophageal cancer	0.000241	0.000866	CcSEcCtD
Posaconazole—Arthralgia—Capecitabine—esophageal cancer	0.00024	0.000862	CcSEcCtD
Posaconazole—Myalgia—Capecitabine—esophageal cancer	0.00024	0.000862	CcSEcCtD
Posaconazole—Chest pain—Capecitabine—esophageal cancer	0.00024	0.000862	CcSEcCtD
Posaconazole—Pharyngitis—Methotrexate—esophageal cancer	0.000239	0.000859	CcSEcCtD
Posaconazole—Anxiety—Capecitabine—esophageal cancer	0.000239	0.000859	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000238	0.000856	CcSEcCtD
Posaconazole—Urinary tract disorder—Methotrexate—esophageal cancer	0.000238	0.000855	CcSEcCtD
Posaconazole—Discomfort—Capecitabine—esophageal cancer	0.000237	0.000852	CcSEcCtD
Posaconazole—Urethral disorder—Methotrexate—esophageal cancer	0.000236	0.000849	CcSEcCtD
Posaconazole—Dry mouth—Capecitabine—esophageal cancer	0.000235	0.000843	CcSEcCtD
Posaconazole—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—esophageal cancer	0.000232	0.0229	CbGpPWpGaD
Posaconazole—Confusional state—Capecitabine—esophageal cancer	0.000232	0.000833	CcSEcCtD
Posaconazole—Oedema—Capecitabine—esophageal cancer	0.00023	0.000826	CcSEcCtD
Posaconazole—Hypersensitivity—Cisplatin—esophageal cancer	0.00023	0.000826	CcSEcCtD
Posaconazole—Infection—Capecitabine—esophageal cancer	0.000228	0.000821	CcSEcCtD
Posaconazole—Erythema multiforme—Methotrexate—esophageal cancer	0.000228	0.000819	CcSEcCtD
Posaconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.000227	0.0223	CbGpPWpGaD
Posaconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.000227	0.0223	CbGpPWpGaD
Posaconazole—Shock—Capecitabine—esophageal cancer	0.000226	0.000813	CcSEcCtD
Posaconazole—Nervous system disorder—Capecitabine—esophageal cancer	0.000225	0.00081	CcSEcCtD
Posaconazole—Eye disorder—Methotrexate—esophageal cancer	0.000225	0.000809	CcSEcCtD
Posaconazole—Thrombocytopenia—Capecitabine—esophageal cancer	0.000225	0.000809	CcSEcCtD
Posaconazole—Tinnitus—Methotrexate—esophageal cancer	0.000225	0.000807	CcSEcCtD
Posaconazole—Tachycardia—Capecitabine—esophageal cancer	0.000224	0.000806	CcSEcCtD
Posaconazole—Asthenia—Cisplatin—esophageal cancer	0.000224	0.000804	CcSEcCtD
Posaconazole—Cardiac disorder—Methotrexate—esophageal cancer	0.000224	0.000804	CcSEcCtD
Posaconazole—Skin disorder—Capecitabine—esophageal cancer	0.000223	0.000803	CcSEcCtD
Posaconazole—Hyperhidrosis—Capecitabine—esophageal cancer	0.000222	0.000799	CcSEcCtD
Posaconazole—Anorexia—Capecitabine—esophageal cancer	0.000219	0.000788	CcSEcCtD
Posaconazole—Angiopathy—Methotrexate—esophageal cancer	0.000219	0.000786	CcSEcCtD
Posaconazole—Immune system disorder—Methotrexate—esophageal cancer	0.000218	0.000782	CcSEcCtD
Posaconazole—Mediastinal disorder—Methotrexate—esophageal cancer	0.000217	0.00078	CcSEcCtD
Posaconazole—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.000217	0.0213	CbGpPWpGaD
Posaconazole—Chills—Methotrexate—esophageal cancer	0.000216	0.000777	CcSEcCtD
Posaconazole—Hypotension—Capecitabine—esophageal cancer	0.000215	0.000772	CcSEcCtD
Posaconazole—Diarrhoea—Cisplatin—esophageal cancer	0.000213	0.000767	CcSEcCtD
Posaconazole—Alopecia—Methotrexate—esophageal cancer	0.000213	0.000765	CcSEcCtD
Posaconazole—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.000212	0.0209	CbGpPWpGaD
Posaconazole—Mental disorder—Methotrexate—esophageal cancer	0.000211	0.000759	CcSEcCtD
Posaconazole—CYP3A4—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.00021	0.0207	CbGpPWpGaD
Posaconazole—Erythema—Methotrexate—esophageal cancer	0.00021	0.000754	CcSEcCtD
Posaconazole—Malnutrition—Methotrexate—esophageal cancer	0.00021	0.000754	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000209	0.000753	CcSEcCtD
Posaconazole—Insomnia—Capecitabine—esophageal cancer	0.000208	0.000747	CcSEcCtD
Posaconazole—Paraesthesia—Capecitabine—esophageal cancer	0.000206	0.000742	CcSEcCtD
Posaconazole—Dysgeusia—Methotrexate—esophageal cancer	0.000205	0.000738	CcSEcCtD
Posaconazole—Dyspnoea—Capecitabine—esophageal cancer	0.000205	0.000737	CcSEcCtD
Posaconazole—Back pain—Methotrexate—esophageal cancer	0.000203	0.000729	CcSEcCtD
Posaconazole—Dyspepsia—Capecitabine—esophageal cancer	0.000202	0.000727	CcSEcCtD
Posaconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.000202	0.0199	CbGpPWpGaD
Posaconazole—Decreased appetite—Capecitabine—esophageal cancer	0.0002	0.000718	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000199	0.000713	CcSEcCtD
Posaconazole—Vomiting—Cisplatin—esophageal cancer	0.000198	0.000713	CcSEcCtD
Posaconazole—Fatigue—Capecitabine—esophageal cancer	0.000198	0.000712	CcSEcCtD
Posaconazole—Vision blurred—Methotrexate—esophageal cancer	0.000198	0.00071	CcSEcCtD
Posaconazole—Rash—Cisplatin—esophageal cancer	0.000197	0.000707	CcSEcCtD
Posaconazole—Constipation—Capecitabine—esophageal cancer	0.000197	0.000707	CcSEcCtD
Posaconazole—Pain—Capecitabine—esophageal cancer	0.000197	0.000707	CcSEcCtD
Posaconazole—Dermatitis—Cisplatin—esophageal cancer	0.000196	0.000706	CcSEcCtD
Posaconazole—Ill-defined disorder—Methotrexate—esophageal cancer	0.000195	0.000699	CcSEcCtD
Posaconazole—Anaemia—Methotrexate—esophageal cancer	0.000194	0.000697	CcSEcCtD
Posaconazole—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.000193	0.019	CbGpPWpGaD
Posaconazole—ABCB1—ABC-family proteins mediated transport—ABCC2—esophageal cancer	0.000193	0.019	CbGpPWpGaD
Posaconazole—Feeling abnormal—Capecitabine—esophageal cancer	0.000189	0.000681	CcSEcCtD
Posaconazole—Malaise—Methotrexate—esophageal cancer	0.000189	0.00068	CcSEcCtD
Posaconazole—Vertigo—Methotrexate—esophageal cancer	0.000188	0.000677	CcSEcCtD
Posaconazole—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000188	0.000676	CcSEcCtD
Posaconazole—Leukopenia—Methotrexate—esophageal cancer	0.000188	0.000675	CcSEcCtD
Posaconazole—Nausea—Cisplatin—esophageal cancer	0.000185	0.000666	CcSEcCtD
Posaconazole—Cough—Methotrexate—esophageal cancer	0.000183	0.000658	CcSEcCtD
Posaconazole—Urticaria—Capecitabine—esophageal cancer	0.000183	0.000656	CcSEcCtD
Posaconazole—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.000182	0.0179	CbGpPWpGaD
Posaconazole—Abdominal pain—Capecitabine—esophageal cancer	0.000182	0.000653	CcSEcCtD
Posaconazole—Body temperature increased—Capecitabine—esophageal cancer	0.000182	0.000653	CcSEcCtD
Posaconazole—Convulsion—Methotrexate—esophageal cancer	0.000182	0.000653	CcSEcCtD
Posaconazole—Myalgia—Methotrexate—esophageal cancer	0.000179	0.000642	CcSEcCtD
Posaconazole—Chest pain—Methotrexate—esophageal cancer	0.000179	0.000642	CcSEcCtD
Posaconazole—Arthralgia—Methotrexate—esophageal cancer	0.000179	0.000642	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000177	0.000637	CcSEcCtD
Posaconazole—Discomfort—Methotrexate—esophageal cancer	0.000176	0.000634	CcSEcCtD
Posaconazole—Confusional state—Methotrexate—esophageal cancer	0.000173	0.00062	CcSEcCtD
Posaconazole—Infection—Methotrexate—esophageal cancer	0.00017	0.000611	CcSEcCtD
Posaconazole—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.00017	0.0167	CbGpPWpGaD
Posaconazole—Hypersensitivity—Capecitabine—esophageal cancer	0.000169	0.000609	CcSEcCtD
Posaconazole—Nervous system disorder—Methotrexate—esophageal cancer	0.000168	0.000603	CcSEcCtD
Posaconazole—Thrombocytopenia—Methotrexate—esophageal cancer	0.000168	0.000602	CcSEcCtD
Posaconazole—Skin disorder—Methotrexate—esophageal cancer	0.000166	0.000597	CcSEcCtD
Posaconazole—Hyperhidrosis—Methotrexate—esophageal cancer	0.000165	0.000595	CcSEcCtD
Posaconazole—Asthenia—Capecitabine—esophageal cancer	0.000165	0.000593	CcSEcCtD
Posaconazole—Anorexia—Methotrexate—esophageal cancer	0.000163	0.000586	CcSEcCtD
Posaconazole—Pruritus—Capecitabine—esophageal cancer	0.000163	0.000585	CcSEcCtD
Posaconazole—Hypotension—Methotrexate—esophageal cancer	0.00016	0.000575	CcSEcCtD
Posaconazole—Diarrhoea—Capecitabine—esophageal cancer	0.000157	0.000565	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000156	0.00056	CcSEcCtD
Posaconazole—Insomnia—Methotrexate—esophageal cancer	0.000155	0.000556	CcSEcCtD
Posaconazole—Paraesthesia—Methotrexate—esophageal cancer	0.000154	0.000552	CcSEcCtD
Posaconazole—Dyspnoea—Methotrexate—esophageal cancer	0.000153	0.000548	CcSEcCtD
Posaconazole—Somnolence—Methotrexate—esophageal cancer	0.000152	0.000547	CcSEcCtD
Posaconazole—CYP3A4—Xenobiotics—CYP2A6—esophageal cancer	0.000152	0.015	CbGpPWpGaD
Posaconazole—Dizziness—Capecitabine—esophageal cancer	0.000152	0.000546	CcSEcCtD
Posaconazole—Dyspepsia—Methotrexate—esophageal cancer	0.000151	0.000541	CcSEcCtD
Posaconazole—Decreased appetite—Methotrexate—esophageal cancer	0.000149	0.000535	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000148	0.000531	CcSEcCtD
Posaconazole—Fatigue—Methotrexate—esophageal cancer	0.000148	0.00053	CcSEcCtD
Posaconazole—Pain—Methotrexate—esophageal cancer	0.000146	0.000526	CcSEcCtD
Posaconazole—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.000146	0.0144	CbGpPWpGaD
Posaconazole—Vomiting—Capecitabine—esophageal cancer	0.000146	0.000525	CcSEcCtD
Posaconazole—Rash—Capecitabine—esophageal cancer	0.000145	0.000521	CcSEcCtD
Posaconazole—Dermatitis—Capecitabine—esophageal cancer	0.000145	0.000521	CcSEcCtD
Posaconazole—Headache—Capecitabine—esophageal cancer	0.000144	0.000518	CcSEcCtD
Posaconazole—Feeling abnormal—Methotrexate—esophageal cancer	0.000141	0.000507	CcSEcCtD
Posaconazole—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00014	0.000503	CcSEcCtD
Posaconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.00014	0.0137	CbGpPWpGaD
Posaconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.00014	0.0137	CbGpPWpGaD
Posaconazole—Nausea—Capecitabine—esophageal cancer	0.000137	0.000491	CcSEcCtD
Posaconazole—Urticaria—Methotrexate—esophageal cancer	0.000136	0.000489	CcSEcCtD
Posaconazole—Abdominal pain—Methotrexate—esophageal cancer	0.000135	0.000486	CcSEcCtD
Posaconazole—Body temperature increased—Methotrexate—esophageal cancer	0.000135	0.000486	CcSEcCtD
Posaconazole—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.000133	0.0131	CbGpPWpGaD
Posaconazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.000131	0.0129	CbGpPWpGaD
Posaconazole—Hypersensitivity—Methotrexate—esophageal cancer	0.000126	0.000453	CcSEcCtD
Posaconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.000124	0.0123	CbGpPWpGaD
Posaconazole—Asthenia—Methotrexate—esophageal cancer	0.000123	0.000441	CcSEcCtD
Posaconazole—Pruritus—Methotrexate—esophageal cancer	0.000121	0.000435	CcSEcCtD
Posaconazole—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.000118	0.0116	CbGpPWpGaD
Posaconazole—Diarrhoea—Methotrexate—esophageal cancer	0.000117	0.000421	CcSEcCtD
Posaconazole—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.000115	0.0113	CbGpPWpGaD
Posaconazole—Dizziness—Methotrexate—esophageal cancer	0.000113	0.000407	CcSEcCtD
Posaconazole—Vomiting—Methotrexate—esophageal cancer	0.000109	0.000391	CcSEcCtD
Posaconazole—Rash—Methotrexate—esophageal cancer	0.000108	0.000388	CcSEcCtD
Posaconazole—Dermatitis—Methotrexate—esophageal cancer	0.000108	0.000387	CcSEcCtD
Posaconazole—Headache—Methotrexate—esophageal cancer	0.000107	0.000385	CcSEcCtD
Posaconazole—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000104	0.0103	CbGpPWpGaD
Posaconazole—Nausea—Methotrexate—esophageal cancer	0.000102	0.000365	CcSEcCtD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—ENO1—esophageal cancer	9.01e-05	0.00886	CbGpPWpGaD
Posaconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	8.87e-05	0.00873	CbGpPWpGaD
Posaconazole—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	8.82e-05	0.00868	CbGpPWpGaD
Posaconazole—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	8.75e-05	0.00861	CbGpPWpGaD
Posaconazole—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	8.31e-05	0.00818	CbGpPWpGaD
Posaconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—esophageal cancer	8.26e-05	0.00813	CbGpPWpGaD
Posaconazole—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	7.73e-05	0.00761	CbGpPWpGaD
Posaconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	7.19e-05	0.00707	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	7.15e-05	0.00704	CbGpPWpGaD
Posaconazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	6.93e-05	0.00682	CbGpPWpGaD
Posaconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	6.61e-05	0.0065	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—HMOX1—esophageal cancer	6.57e-05	0.00647	CbGpPWpGaD
Posaconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	6.32e-05	0.00622	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—SMAD4—esophageal cancer	6.31e-05	0.00621	CbGpPWpGaD
Posaconazole—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	6.3e-05	0.0062	CbGpPWpGaD
Posaconazole—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	6.24e-05	0.00614	CbGpPWpGaD
Posaconazole—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	5.92e-05	0.00583	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	5.55e-05	0.00547	CbGpPWpGaD
Posaconazole—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	5.45e-05	0.00536	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—HIF1A—esophageal cancer	5.16e-05	0.00508	CbGpPWpGaD
Posaconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	5.12e-05	0.00504	CbGpPWpGaD
Posaconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	5.09e-05	0.00501	CbGpPWpGaD
Posaconazole—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	5.03e-05	0.00495	CbGpPWpGaD
Posaconazole—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	4.86e-05	0.00478	CbGpPWpGaD
Posaconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	4.79e-05	0.00471	CbGpPWpGaD
Posaconazole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	4.73e-05	0.00465	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	4.69e-05	0.00462	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—ADH7—esophageal cancer	4.68e-05	0.00461	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	4.22e-05	0.00415	CbGpPWpGaD
Posaconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	4.13e-05	0.00406	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	4.11e-05	0.00404	CbGpPWpGaD
Posaconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	3.88e-05	0.00382	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	3.82e-05	0.00376	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	3.78e-05	0.00372	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	3.77e-05	0.00371	CbGpPWpGaD
Posaconazole—ABCB1—Allograft Rejection—CASP8—esophageal cancer	3.67e-05	0.00361	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	3.55e-05	0.00349	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	3.5e-05	0.00345	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	3.45e-05	0.0034	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	3.28e-05	0.00323	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	3.26e-05	0.00321	CbGpPWpGaD
Posaconazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	3.17e-05	0.00312	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	3.07e-05	0.00302	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	2.91e-05	0.00286	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	2.89e-05	0.00285	CbGpPWpGaD
Posaconazole—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	2.87e-05	0.00283	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	2.78e-05	0.00274	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	2.78e-05	0.00273	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	2.75e-05	0.00271	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	2.72e-05	0.00268	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	2.7e-05	0.00265	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	2.66e-05	0.00262	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	2.66e-05	0.00262	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	2.58e-05	0.00254	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	2.55e-05	0.00251	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	2.19e-05	0.00216	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	2.16e-05	0.00213	CbGpPWpGaD
Posaconazole—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	2.06e-05	0.00203	CbGpPWpGaD
Posaconazole—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	2.03e-05	0.002	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	2.02e-05	0.00198	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	1.83e-05	0.0018	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	1.81e-05	0.00178	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	1.8e-05	0.00177	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—BLVRB—esophageal cancer	1.8e-05	0.00177	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—SLC52A3—esophageal cancer	1.8e-05	0.00177	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	1.55e-05	0.00153	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CA1—esophageal cancer	1.53e-05	0.0015	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—SLC10A2—esophageal cancer	1.53e-05	0.0015	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	1.51e-05	0.00148	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	1.48e-05	0.00145	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CA2—esophageal cancer	1.4e-05	0.00138	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	1.33e-05	0.00131	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ADH7—esophageal cancer	1.3e-05	0.00128	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PLCE1—esophageal cancer	1.3e-05	0.00128	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.29e-05	0.00127	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.23e-05	0.00121	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ADH1B—esophageal cancer	1.14e-05	0.00112	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.12e-05	0.0011	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.11e-05	0.00109	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.11e-05	0.00109	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—TYMP—esophageal cancer	1.09e-05	0.00107	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.07e-05	0.00105	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.06e-05	0.00104	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.05e-05	0.00103	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ALOX15—esophageal cancer	1.03e-05	0.00102	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTO1—esophageal cancer	9.85e-06	0.00097	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—TPI1—esophageal cancer	9.85e-06	0.00097	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ALDOB—esophageal cancer	9.45e-06	0.00093	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CA1—esophageal cancer	9.42e-06	0.000927	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—SLC10A2—esophageal cancer	9.42e-06	0.000927	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GAPDH—esophageal cancer	9.09e-06	0.000895	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	9.08e-06	0.000893	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CRABP1—esophageal cancer	9.01e-06	0.000887	CbGpPWpGaD
Posaconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	8.78e-06	0.000864	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CA2—esophageal cancer	8.62e-06	0.000848	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GNG7—esophageal cancer	8.57e-06	0.000844	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ALDH2—esophageal cancer	8.03e-06	0.00079	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PLCE1—esophageal cancer	8.01e-06	0.000788	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ADH7—esophageal cancer	8.01e-06	0.000788	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—GSTT1—esophageal cancer	7.64e-06	0.000752	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CYP2A6—esophageal cancer	7.55e-06	0.000743	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PTGS1—esophageal cancer	7.16e-06	0.000705	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—ENO1—esophageal cancer	7.16e-06	0.000705	CbGpPWpGaD
Posaconazole—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.15e-06	0.000704	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PSME1—esophageal cancer	7.05e-06	0.000694	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PSME2—esophageal cancer	7.05e-06	0.000694	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.02e-06	0.000691	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—TYMP—esophageal cancer	6.71e-06	0.000661	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.53e-06	0.000643	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.36e-06	0.000626	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CYP1B1—esophageal cancer	6.09e-06	0.000599	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.07e-06	0.000597	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—TPI1—esophageal cancer	6.07e-06	0.000597	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ALDOB—esophageal cancer	5.82e-06	0.000573	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CYP19A1—esophageal cancer	5.72e-06	0.000563	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.6e-06	0.000551	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.55e-06	0.000546	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GNG7—esophageal cancer	5.28e-06	0.00052	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—HMOX1—esophageal cancer	5.22e-06	0.000514	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ALDH2—esophageal cancer	4.95e-06	0.000487	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.71e-06	0.000463	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.65e-06	0.000458	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.41e-06	0.000434	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ENO1—esophageal cancer	4.41e-06	0.000434	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PSME1—esophageal cancer	4.35e-06	0.000428	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PSME2—esophageal cancer	4.35e-06	0.000428	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.75e-06	0.000369	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.53e-06	0.000347	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—CREBBP—esophageal cancer	3.35e-06	0.00033	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.22e-06	0.000317	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.09e-06	0.000304	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—NOS3—esophageal cancer	3e-06	0.000295	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PTGS2—esophageal cancer	2.74e-06	0.00027	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—EP300—esophageal cancer	2.28e-06	0.000225	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.06e-06	0.000203	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—NOS3—esophageal cancer	1.85e-06	0.000182	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.69e-06	0.000166	CbGpPWpGaD
Posaconazole—ABCB1—Metabolism—PIK3CA—esophageal cancer	1.69e-06	0.000166	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—EP300—esophageal cancer	1.41e-06	0.000138	CbGpPWpGaD
Posaconazole—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.04e-06	0.000102	CbGpPWpGaD
